BioStem Technologies, Inc. (OTCMKTS:BSEM – Get Free Report) was the target of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 37,400 shares, a growth of 152.7% from the March 31st total of 14,800 shares. Based on an average daily trading volume, of 68,700 shares, the short-interest ratio is presently 0.5 days.
BioStem Technologies Price Performance
Shares of OTCMKTS BSEM opened at 9.11 on Friday. The business’s 50 day moving average price is 10.38. BioStem Technologies has a 1 year low of 1.20 and a 1 year high of 15.50.
BioStem Technologies (OTCMKTS:BSEM – Get Free Report) last announced its quarterly earnings results on Monday, April 1st. The company reported -0.14 earnings per share (EPS) for the quarter. The firm had revenue of 11.44 million for the quarter, compared to analyst estimates of 11.40 million. On average, sell-side analysts expect that BioStem Technologies will post 3.14 EPS for the current fiscal year.
About BioStem Technologies
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Featured Stories
- Five stocks we like better than BioStem Technologies
- What Are the FAANG Stocks and Are They Good Investments?
- MarketBeat Week in Review – 4/22 – 4/26
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Stocks Leading the U.S. Agriculture Comeback
- High Flyers: 3 Natural Gas Stocks for March 2022
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for BioStem Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioStem Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
